Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-09MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 2170 units of Mineralys Therapeutics, Inc. securities around 2026-04-09, with aggregate market value of $59,414.60. The total outstanding units is 82399478.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions i...
Mid CapBiotechnology
2026-04-09GLUE144PHILIP NICKSON plan to sell securities of MONTE ROSA THERAPEUTICS, INC. under Form 144MEDIUM
PHILIP NICKSON filed Form 144 to notify SEC of plan to sell 5845 units of MONTE ROSA THERAPEUTICS, INC. securities around 2026-04-09, with aggregate market value of $103,412.66. The total outstanding units is 80015667.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-04-09Monte Rosa Therapeutics, Inc.144PHILIP NICKSON plan to sell securities of MONTE ROSA THERAPEUTICS, INC. under Form 144DuplicateMEDIUM
PHILIP NICKSON filed Form 144 to notify SEC of plan to sell 5845 units of MONTE ROSA THERAPEUTICS, INC. securities around 2026-04-09, with aggregate market value of $103,412.66. The total outstanding units is 80015667.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-04-09ACET144OrbiMed Genesis Master Fund, L.P. plan to sell securities of Adicet Bio, Inc. under Form 144MEDIUM
OrbiMed Genesis Master Fund, L.P. filed Form 144 to notify SEC of plan to sell 78499 units of Adicet Bio, Inc. securities around 2026-04-09, with aggregate market value of $514,168.45. The total outstanding units is 9596407.0. The amount planned to be sold represents 0.82% of total outstanding units; ...
Micro CapBiotechnology
2026-04-09Mineralys Therapeutics, Inc.144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144DuplicateMEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 2170 units of Mineralys Therapeutics, Inc. securities around 2026-04-09, with aggregate market value of $59,414.60. The total outstanding units is 82399478.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions i...
Mid CapBiotechnology
2026-04-09DNTH144RYAN SAVITZ plan to sell securities of DIANTHUS THERAPEUTICS INC under Form 144MEDIUM
RYAN SAVITZ filed Form 144 to notify SEC of plan to sell 8224 units of DIANTHUS THERAPEUTICS INC securities around 2026-04-09, with aggregate market value of $719,435.52. The total outstanding units is 44471094.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past 3 m...
Mid CapBiotechnology